1. Home
  2. FLGT vs THW Comparison

FLGT vs THW Comparison

Compare FLGT & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • THW
  • Stock Information
  • Founded
  • FLGT 2011
  • THW 2015
  • Country
  • FLGT United States
  • THW United States
  • Employees
  • FLGT N/A
  • THW N/A
  • Industry
  • FLGT Medical Specialities
  • THW Finance Companies
  • Sector
  • FLGT Health Care
  • THW Finance
  • Exchange
  • FLGT Nasdaq
  • THW Nasdaq
  • Market Cap
  • FLGT 508.7M
  • THW 454.0M
  • IPO Year
  • FLGT 2016
  • THW N/A
  • Fundamental
  • Price
  • FLGT $17.62
  • THW $11.27
  • Analyst Decision
  • FLGT Hold
  • THW
  • Analyst Count
  • FLGT 1
  • THW 0
  • Target Price
  • FLGT $16.00
  • THW N/A
  • AVG Volume (30 Days)
  • FLGT 727.9K
  • THW 149.9K
  • Earning Date
  • FLGT 05-02-2025
  • THW 01-01-0001
  • Dividend Yield
  • FLGT N/A
  • THW 10.76%
  • EPS Growth
  • FLGT N/A
  • THW N/A
  • EPS
  • FLGT N/A
  • THW N/A
  • Revenue
  • FLGT $283,470,000.00
  • THW N/A
  • Revenue This Year
  • FLGT $11.70
  • THW N/A
  • Revenue Next Year
  • FLGT $9.90
  • THW N/A
  • P/E Ratio
  • FLGT N/A
  • THW N/A
  • Revenue Growth
  • FLGT N/A
  • THW N/A
  • 52 Week Low
  • FLGT $14.57
  • THW $9.76
  • 52 Week High
  • FLGT $25.11
  • THW $14.89
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 57.62
  • THW 28.49
  • Support Level
  • FLGT $16.51
  • THW $11.80
  • Resistance Level
  • FLGT $17.20
  • THW $12.03
  • Average True Range (ATR)
  • FLGT 0.56
  • THW 0.13
  • MACD
  • FLGT 0.04
  • THW -0.06
  • Stochastic Oscillator
  • FLGT 98.23
  • THW 4.36

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About THW abrdn World Healthcare Fund Shares of Beneficial Interest

Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies engaged in the healthcare industry. The company's investment portfolio comprises investments in different sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other areas.

Share on Social Networks: